WallStreetZenWallStreetZen

NYSE: NUVB
Nuvation Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NUVB

Based on 7 analysts offering 12 month price targets for Nuvation Bio Inc

Min Forecast
$10.00+109.64%
Avg Forecast
$14.29+199.5%
Max Forecast
$21.00+340.25%

Should I buy or sell NUVB stock?

Based on 8 analysts offering ratings for Nuvation Bio Inc.

Strong Buy
Strong Buy
4 analysts 50%
Buy
4 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NUVB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NUVB as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their NUVB stock forecasts and price targets.

NUVB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-30
lockedlocked$00.00+00.00%2026-09-16
lockedlocked$00.00+00.00%2026-09-16
lockedlocked$00.00+00.00%2026-08-21
lockedlocked$00.00+00.00%2026-08-18Find Out Why
RBC Capital
Top 6%
95
BuyMaintains$20.00+319.29%2026-08-07
HC Wainwright & Co.
Top 12%
89
BuyMaintains$21.00+340.25%2026-07-27
Truist Securities
Top 2%
99
Strong BuyMaintains$13.00+172.54%2026-07-07

1 of 1

Forecast return on equity

Is NUVB forecast to generate an efficient return?

Company
18.34%
Industry
21.05%
Market
175.22%
NUVB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NUVB forecast to generate an efficient return on assets?

Company
6.25%
Industry
22.87%
NUVB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NUVB earnings per share forecast

What is NUVB's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.21
Avg 3 year Forecast
$0.03

NUVB revenue forecast

What is NUVB's revenue in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$197.9M+16.46%
Avg 2 year Forecast
$280.0M+64.82%
Avg 3 year Forecast
$424.6M+149.92%
NUVB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NUVB revenue growth forecast

How is NUVB forecast to perform vs Biotechnology companies and vs the US market?

Company
34.36%
Industry
31.15%
Market
12.98%
NUVB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NUVB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NUVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NUVB$4.77$14.29+199.50%Strong Buy
RARE$16.78$30.58+82.23%Buy
STOK$26.35$45.14+71.32%Strong Buy
REPL$17.39$22.00+26.51%Strong Buy
URGN$33.48$57.00+70.25%Strong Buy
View Top Biotech Stocks

Nuvation Bio Stock Forecast FAQ

Is Nuvation Bio Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: NUVB) stock is to Strong Buy NUVB stock.

Out of 8 analysts, 4 (50%) are recommending NUVB as a Strong Buy, 4 (50%) are recommending NUVB as a Buy, 0 (0%) are recommending NUVB as a Hold, 0 (0%) are recommending NUVB as a Sell, and 0 (0%) are recommending NUVB as a Strong Sell.

If you're new to stock investing, here's how to buy Nuvation Bio stock.

What is NUVB's earnings growth forecast for 2026-2028?

(NYSE: NUVB) Nuvation Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.01%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.56%.

Nuvation Bio's earnings in 2026 is -$149,827,000.On average, 15 Wall Street analysts forecast NUVB's earnings for 2026 to be -$142,766,707, with the lowest NUVB earnings forecast at -$151,404,338, and the highest NUVB earnings forecast at -$125,350,994. On average, 15 Wall Street analysts forecast NUVB's earnings for 2027 to be -$75,280,821, with the lowest NUVB earnings forecast at -$168,609,376, and the highest NUVB earnings forecast at -$23,595,481.

In 2028, NUVB is forecast to generate $10,990,157 in earnings, with the lowest earnings forecast at -$110,112,246 and the highest earnings forecast at $151,158,552.

What is NUVB's revenue growth forecast for 2026-2028?

(NYSE: NUVB) Nuvation Bio's forecast annual revenue growth rate of 34.36% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.15%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.98%.

Nuvation Bio's revenue in 2026 is $169,900,000.On average, 15 Wall Street analysts forecast NUVB's revenue for 2026 to be $69,473,242,881, with the lowest NUVB revenue forecast at $60,631,959,874, and the highest NUVB revenue forecast at $81,390,365,409. On average, 15 Wall Street analysts forecast NUVB's revenue for 2027 to be $98,325,038,937, with the lowest NUVB revenue forecast at $74,620,709,477, and the highest NUVB revenue forecast at $130,719,668,414.

In 2028, NUVB is forecast to generate $149,093,947,196 in revenue, with the lowest revenue forecast at $102,471,804,319 and the highest revenue forecast at $222,682,354,369.

What is NUVB's forecast return on assets (ROA) for 2026-2029?

(NYSE: NUVB) forecast ROA is 6.25%, which is lower than the forecast US Biotechnology industry average of 22.87%.

What is NUVB's Price Target?

According to 7 Wall Street analysts that have issued a 1 year NUVB price target, the average NUVB price target is $14.29, with the highest NUVB stock price forecast at $21.00 and the lowest NUVB stock price forecast at $10.00.

On average, Wall Street analysts predict that Nuvation Bio's share price could reach $14.29 by Sep 30, 2027. The average Nuvation Bio stock price prediction forecasts a potential upside of 199.5% from the current NUVB share price of $4.77.

What is NUVB's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: NUVB) Nuvation Bio's current Earnings Per Share (EPS) is -$0.43. On average, analysts forecast that NUVB's EPS will be -$0.41 for 2026, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at -$0.36. On average, analysts forecast that NUVB's EPS will be -$0.21 for 2027, with the lowest EPS forecast at -$0.48, and the highest EPS forecast at -$0.07. In 2028, NUVB's EPS is forecast to hit $0.03 (min: -$0.31, max: $0.43).

What is NUVB's forecast return on equity (ROE) for 2026-2029?

(NYSE: NUVB) forecast ROE is 18.34%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.